Business Services Industry

CuraGen Files for Initial Public Offering

Business Wire, Oct 16, 1997

NEW HAVEN, Conn.--(BUSINESS WIRE)--Oct. 16, 1997--CuraGen Corp., a Connecticut-based company, announced today that it has filed a registration statement with the Securities and Exchange Commission for a proposed initial public offering of its common stock.

CuraGen develops and applies genomics technologies, processes and information systems for gene-based drug discovery, development and pharmacogenomics.

The terms of the public offering are not yet disclosed and will be made only by prospectus. Morgan Stanley Dean Witter, Lehman Brothers and Bear, Stearns & Co. Inc. will act as managing underwriters of the offering.

A registration statement on Form S-1 relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may any offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

CONTACT: CuraGen Corp.

David M. Wurzer, 888/GENOMICS (Executive VP and CFO)

investors@curagen.com

COPYRIGHT 1997 Business Wire
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale